首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1315241篇
  免费   96628篇
  国内免费   2464篇
耳鼻咽喉   18723篇
儿科学   43840篇
妇产科学   38494篇
基础医学   192070篇
口腔科学   36358篇
临床医学   111136篇
内科学   260667篇
皮肤病学   27822篇
神经病学   102247篇
特种医学   51345篇
外国民族医学   368篇
外科学   202594篇
综合类   27737篇
现状与发展   1篇
一般理论   316篇
预防医学   95971篇
眼科学   30152篇
药学   100538篇
  8篇
中国医学   2950篇
肿瘤学   70996篇
  2018年   13583篇
  2016年   11016篇
  2015年   12611篇
  2014年   17213篇
  2013年   26189篇
  2012年   36556篇
  2011年   39318篇
  2010年   22904篇
  2009年   21159篇
  2008年   37513篇
  2007年   40540篇
  2006年   40875篇
  2005年   40189篇
  2004年   38538篇
  2003年   37475篇
  2002年   36793篇
  2001年   59331篇
  2000年   61113篇
  1999年   51612篇
  1998年   14602篇
  1997年   13121篇
  1996年   13364篇
  1995年   12602篇
  1994年   11950篇
  1993年   11085篇
  1992年   41172篇
  1991年   40511篇
  1990年   40029篇
  1989年   38876篇
  1988年   36260篇
  1987年   35457篇
  1986年   33836篇
  1985年   32240篇
  1984年   24003篇
  1983年   20875篇
  1982年   12433篇
  1981年   10990篇
  1979年   22663篇
  1978年   15907篇
  1977年   13772篇
  1976年   13007篇
  1975年   14226篇
  1974年   16694篇
  1973年   16097篇
  1972年   15323篇
  1971年   14240篇
  1970年   13219篇
  1969年   12731篇
  1968年   11978篇
  1967年   10465篇
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
61.
The aim of the present study was to evaluate the antimicrobial activity of two synbiotic combinations, Lactobacillus fermentum with short-chain fructooligosaccharides (FOS-LF) and Bifidobacterium longum with isomaltooligosaccharides (IMO-BL), against enterohaemorrhagic Escherichia coli O157:H7 and enteropathogenic E. coli O86. Antimicrobial activity was determined (1) by co-culturing the synbiotics and pathogens in batch cultures, and (2) with the three-stage continuous culture system (gut model), inoculated with faecal slurry from an elderly donor. In the co-culture experiments, IMO-BL was significantly inhibitory to both E. coli strains, while FOS-LF was slightly inhibitory or not inhibitory. Factors other than acid production appeared to play a role in the inhibition. In the gut models, both synbiotics effectively inhibited E. coli O157 in the first vessel, but not in vessels 2 and 3. E. coli O86 was not significantly inhibited.  相似文献   
62.
63.
64.

Background

Arterial vascular anomalies in patients undergoing kidney transplantation (KT) are correlated with a higher incidence of early surgical complications, potentially causing graft loss. Arterial reconstruction allows patients to overcome these surgical challenges, thus minimizing the risk of poor outcomes. The aim of the present study is to retrospectively investigate the safety and effectiveness of the multiple arterial reconstruction technique with a Teflon patch in case of an unavailable aortic patch: to do so, surgical complications, graft function, and patient survival were evaluated.

Methods

During the period January 2009 to August 2016, 202 adult deceased-donor KTs were performed at our center. Group A (n = 27; reconstruction of multiple arteries) and Group B (n = 175; control group) were compared.

Results

No differences were observed between the 2 groups in terms of early postoperative course, with no vascular complication observed in Group A. No vascular patch infections were reported, nor longer cold ischemia time rates. Similarly, long-term survival rates were similar between the 2 groups.

Conclusions

The Teflon-patch arterial reconstruction technique appears to be safe and effective, with an acceptable balance of benefits and potential risks of using a prosthetic material. Studies based on larger series are needed to further validate this approach.  相似文献   
65.

Background

Since recent reports have shown that (-)-Epigallocatechin-3-gallate (EGCG) could be used for treating proliferative and inflammatory disorders, we explored its use for the management of corneal chemical burns.

Materials and methods

Initially, EGCG was assayed on the rabbit corneal epithelial cell line RCE1(5T5) to establish the best testing conditions, and to avoid unwanted outcomes in the experimental animals. Then, we studied its effects on cell proliferation, cell cycle progression and cell differentiation. Afterwards, we instilled EGCG in experimental grade II corneal alkali burns in mice, three times a day up to 21 days, and evaluated by slit lamp examination and histological sections of corneal epithelial, corneal endothelial and stromal edema, as well as the presence of inflammatory cells and neovascularization.

Results

EGCG reduced cell growth and led to a decline in the proportion of proliferative cells in a concentration dependent manner. At 10 μM, EGCG promoted cell differentiation, an effect not related with apoptosis or cytotoxicity. When 10 μM EGCG was instilled in corneal alkali burns in mice three times a day up to 21 days, EGCG significantly reduced corneal opacity and neovascularization. The improved clinical appearance of the cornea was associated to a controlled epithelial growth; epithelial morphology was similar to that observed in normal epithelium and contrasted with the hyperproliferative, desquamating epithelium observed in control burn wounds. EGCG reduced corneal, stromal and endothelial edema, and wound inflammation.

Conclusion

This work constitutes the first evidence for the use of EGCG in the acute phase of a corneal alkali burn, representing a possible novel alternative to improve patient outcomes as an add-on therapy.  相似文献   
66.
67.
68.
69.
Eccrine naevus (EN) is a rare skin hamartoma included in the organoid group of epidermal naevi, histologically defined as focal hyperplasia and/or hypertrophy of eccrine glands. Clinically, EN usually presents as hyperhidrotic patches with no visible skin changes, frequently located on the forearms. The decision to treat EN or not usually depends on the grade of hyperhidrosis, but there is no therapeutic consensus because of the rarity of this condition. We present a case diagnosed as EN in an adult patient with severe localized hyperhidrosis, which was successfully treated with botulinum toxin.  相似文献   
70.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号